chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  As written per ED notes dated 3/9/2021: This 42-year-old female is  here for evaluation of increasing nausea and vomiting. The patient has gotten worse the past 24 hours. She got her second COVID-19 shot yesterday here at the VA Medical Center. She is complaining of consistent nausea and vomiting and can't keep any fluids down. She is here for evaluation of possible dehydration and weakness. The patient feels markedly improved after oral Zofran. I counseled her at length about this is a possible intolerance to the second Covid 19 immunization. She will be discharged home with Zofran 4 mg tablets 3 times a day as needed for nausea #20, increase fluids and rest, no work until Thursday, March 11, 2021. First covid19 vaccine: 2/15/2021, no adverse events Second covid19 vaccine 3/18/2021: presented to ED
pt transferred from SNF to hospital (locally) on 12/23/21 for low Hgb; received a blood transfusion in hospital; acute blood loss anemia most likely GI tract, may be related to prostate CA hx; plan is a colonoscopy; scheduled follow up as outpatient for further work up; 12/27/21 pt dc'd to SNF; COVID test done before leaving; COVID test later found to be positive; pt passed away in the SNF (hospital)
pt was vaxed 6FEB96 & the next day slept from 1130AM-5PM & again the following day; diff to arouse;no fever-not lethargic when awake;notified MD 8FEB;no further episode;
Follow-up info received from the MD on 2/3/03 indicated add'l event details. An MD reported that a female nurse broke a bottle of Prevnar in her hand while drawing a dose on 1/9/03. The nurse's hand was cut and bleeding. The MD noted that the Prevnar did not enter the wound.
Patient given Hep A shot in left deltoid, patient and this RN were discussing the schedule for the Oral Typhoid and weather the patient wanted to get her Hep B shot as well when patient stated she was feeling hot and not well, patient stated that she felt like she would pass out, this RN asked if she needed to lay down in a room with a bed, patient stated she would just lay on the floor of the RN's clinic room where patient went from sitting in the chair to laying on the floor, patient's mother was asked to watch patient for a moment while this RN got the vitals machine, cold pack and another RN to assist. Blood pressure 13:57 78/56, HR 48, patient's legs were elevated to assist in bringing up Blood pressure, cold compress was placed on patient's forehead, patient never lost consciousness and was able to answer the RN appropriately. Vitals were taken again at 16:08 B/P 105/65, HR 72, patient stated she was feeling better and then sat up in the chair with the assistance of the RN's, patient stated she was feeling much better and that she would like to take her Hep B shot. This RN asked if she was sure that she wanted to and that if she did then we would take precautions and lay her down in another room in the event she started feeling the same way again. Hepatitis B shot was given with no reactions.
This case was received from a consumer on 13 May 2008. A consumer reported that his 92-year-old mother received an injection of Influenza Vaccine (manufacturer and lot number not reported) on 29 November 2007. At the time of vaccination, the subject had high blood pressure. Two days after vaccination, on 01 December 2007, the patient began experiencing dizziness, nausea, and vomiting. She was diagnosed with pneumonia, and admitted to the hospital for 14 days. She later developed shingles on her forehead. She died on 12 January 2008; cause of death on the death certificate was "heart attack" according to the patient's son. No autopsy was performed. 6/16/08-records received for 12/03/07-presented obtunded and unresponsive. Felt weak and limp, gurgling and wheezing, falling towards left side. Appeared to improved but had sudden listless and fever, delirious and gurgling. ED assessment:CHF exacerbation. Assessment viral versus bacterial community acquired pneumonia.  7/18/08-records received for DOS 12/4-12/7/07-DC DX: Community-acquired pneumonia. Pulmonary edema. Presented to ED less responsive than baseline. PE:rales.  9/24/08-records receivedOD-cardiac arrest. Probable myocardial infarction. Possible aspiration.
Arm began to itch at injection site and has never stopped over 1 year later. No redness, swelling, or other reaction but itching.
pt recv vax 2JUL97 & 2-3 wk p/vax 16JUL97 pt exp severe hair loss & painful nodules all voer body;later dx w/periarteritis nodosa;also devel a huge area around inj site that looked like a boil & was very sore;
1. Dizziness - Started on 04/10/2021. Continuing in 7th week since vaccination. 2. Tinnitus-  Started 1 week after shot, continuing in 7th week. 3. Headaches and pressure behind the eyes - Stared 1 week after shot, continuing in 7th week. 4. Ear fullness and pressure in ears - Resolved 5 weeks after shot. 5. Off balance during walking- Started on 04/10/21. Continuing in 7th week.
Approximately 24 hours after vaccination, family noted erythema, warmth and swelling of site of vaccination (right deltoid). Erythema and warmth spread until pt seen by this physician today for follow up.
Had Vaccine at 11:30am, left after 11:45am, when got to work i felt naucious and dizzy leading to throwing up. i waited 5 min then when entering work, went to restroom and threw up for the 2nd time around 12:20pm
have contracted A strain Influenza; have contracted A strain Influenza; Initial information received on 03-Mar-2020 regarding an unsolicited valid serious case from a consumer/non-hcp.  This case involves a 50 years old male patient who was diagnosed with strain A influenza (Influenza), while he received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's medical history, past medical treatment, past vaccination and family history were not provided.  In October 2019, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number not reported) via an unknown route at an unknown administration site.  On 03-Mar-2020, the patient have contracted A strain influenza (influenza) (latency about 4 months) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. This event was assessed as medically significant. It was also a case of vaccination failure.  Relevant laboratory test results included: On 03-Mar-2020, the influenza A virus test was positive.  Final diagnosis was influenza.  The patient started oseltamivir phosphate [Tamiflu] as corrective treatment.  The patient was recovering from influenza A.  Information on the batch number is requested.; Sender's Comments: This case concerns a 50 years old male patient who was diagnosed with influenza A virus infection after and despite of vaccination with FLUBLOK QIV. The time to onset is compatible. The lab data confirms the influenza strain A. The patient's past medical history, concomitant medications, immune status and lab tests ruling out predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine and a case of vaccination failure cannot be assessed.
Severe left arm pain and weakness with muscle bulging-unremitting-sent to neurology. The medical record received on 4/2/04 states decreased range of motion. No further calls or complaints from the patient.
Information has been received from a physician concerning 2 pts in there 70's who on 5/17/00, were vaccinated with 1 dose of pneumococcal vaccine 23 polyvalent. Subsequently, the pts developed pain and swelling at the injection site. The pts sought unspecified medical treatment. Additional information has been requested.
Patient received Pfizer COVID vaccine on 1/7/21 (lot # EJ1686), 1/28/21 (lot # EL1283), and 9/8/21 (lot # FE3592).  On 1/11/22, patient admitted to our unit s/p ground-level fall with acute hemorrhagic cystitis and COVID-19 pneumonia. She was discharged home on 1/13/22 (during this hospitalization, patient had mild URI symptoms and no hypoxia). The next AM, patient was found to be hypoxic and patient was admitted back to the hospital on 1/14/22 for COVID pneumonia with acute respiratory failure and hypoxia. As of today (1/18/22), patient is still admitted in our unit.
patient reports upon waking in the morning that he is still have arm/shoulder pain at the injection site. He reports sometimes not being able to lift his left arm above his head
Fever; Body ache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and MYALGIA (Body ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and MYALGIA (Body ache). At the time of the report, PYREXIA (Fever) and MYALGIA (Body ache) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter. Action taken with mRNA-1273 Moderna COVID-19 Vaccine was not applicable   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow-up information on received and does not contain any new information.
pt recv vax & cried inconsolably for 4hr & devel a fever of unspecified degree;pt had recovered @ date of this report;
Information regarding Prevnar (pneumococcal 7-valent conjugate vaccine (diptheria crm197 protein) injection) was received from a consumer regarding a female patient who experienced diarrhea. The patient received the first dose on an unspecified date. Medical History:Relevant medical history was not provided. Product Details: Indication for Prevnar was immunization. Product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day (intramuscular). Concomitant Therapy: Concomitant medicatios were not reported. Event Details: The patient experienced diarrhea ( diarrhea NOS). Related Case(s): The patient experienced diarrhea following receipt of her second dose of Prevnar on an unspecified date and erythema multiforme following receipt of her third dose of Prevnar on 23-Oct-2003, at 10 months of age (see MCN HQWYE671131OCT03 and HQWYE613229OCT03). No additional information was available at the date of this report.
Haedache, body aches and fatigue, at 1:00 PM cramping in bicep below shoulder where I received the shot, 6:00 pm feeling cold, nausea.
Patient past out after receiving Fluzone quadrivalent vaccine and hit his chin on the floor.   He lost consciousness and cut his chin on floor. Patient regained consciousness after a few minutes and felt sick and nauseous.  Paramedics arrived at scene within about 10 -15 minutes while patient sat.  Patient was evaluated by paramedics and Parents chose not to have patient go to the hospital with paramedics as his symptoms improved.
headaches; This spontaneous case was reported by a non-health professional and describes the occurrence of HEADACHE (headaches) in a 73-year-old female patient who received mRNA-1273 (batch no. 036B12A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus.    On 05-May-2021, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 05-May-2021, the patient experienced HEADACHE (headaches). At the time of the report, HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Blood glucose: 40 (Low) in the middle of the night ,sugar is going down to the 40's and 300 (High) in the morning it jumps up to over 300. On 11-May-2021, Blood glucose: 215 (High) This morning it was 215 and patient had not eaten anything.     The action taken with mRNA-1273 (Unknown) was unknown.       no concomitant medication. No treatment provided by the reporter. Patient sugar has been fluctuating like crazy
approximately 4-5 hours after varicella injection given, grandma called c/o child high fever, hoarseness, vomiting. Taken to ER by parent after 5:30 PM. Being treated for strep throat with antibiotics now after visit to ER per grandma.
About 8 hours after vaccine: significant chills, headache, muscle aches - which all continued for approximately 24 hours, and then severity lessened (but effect continued) About 10-12 hours after vaccine: fever, fatigue - which continued for approximately 36 hours, and then fever ended but fatigue continued About 36 hours vaccine: fainting - which happened twice in a 12-hour period
Severe right ankle monoarticular arthritis that woke from sleep. (did experience flu-like symptoms ~36 hrs after inoculation but these were short-lived). Unable to weight-bear despite high dose NSAIDS. While have hx of mild enthesitis, have never had these symptoms before.
Pt had a pre-existing URI when she received intranasal H1N1 vaccine for approximately 1wk before the vaccine. She developed mild croup within 24 hours of the vaccine, not requiring steroid (as of today).
Day 1 Hot welt developed on arm. (Area grew to size of baseball over the course of three days) Day 2 Unable to move right  arm above shoulder.  Day 3 Radiating joint pain running from right arm down spine. Extreme fatigue. Headache. Day 4 Hot welt continues. Headache. Day 5 Hot welt subsided, lump left under skin with gray/blue discoloration. Day 6 Still feeling joint point throughout body.
Information has been received from a nurse referring to a 23 year old female patient. The patient had no drug reactions/allergies. Information regarding concomitant medication and medical history were unknown. On 23-AUG-2016, the patient was vaccinated with 2 doses of RECOMBIVAX HB (10 microgram x 3 doses) (lot # M023892 with expiration date 17-SEP-2017, intramuscular) (inappropriate schedule of vaccine administered). On an unknown date in August 2016, the patient experienced redness and swelling at the injection site. The patient didn't sought medical attention. No treatment was given for the events and no lab diagnostics studies were performed. At the reporting time, the patient was recovering from the events. The causality between the events and the vaccine was not reported. Additional information has been requested.
After the covid vaccines I started heavy mentrual bleeding while having an IUD placed with no bleeding previously while the IUD was inserted.
I received Latera absorbable nasal implants (manufacturer Striker) due to collapsed sinus (intraoperatively).  Within a day or two post op, I started having red lines above the implants which swelled.  At first the doc thought it was an infection and I was given Clindamycin and attempted to culture site (only clear fluid with no notable growth).   I have no history of allergies of any kind. There was no improvement. Then I was put on a course of Methylprednisolone and antihistamines (Cetirizine at night and Fexofenadine during the day) to try to slow the response.  Above the implants is less swollen but still red.  The doc said there is a chance this could be related to the Covid-19 vaccine given the other concerns with facial fillers.  There is a concern that if we don't get the response under control I will have a steroid injection in my nose.  And if that doesn't work, I could have scaring in those locations.  The implant does not absorb for 18 months.
Diabetic ketoacidosis CO2<10 A1C 13.4 Weak/sluggish/lethargic,/urinating a lot
Hives appeared generalized over body, upper lip very swollen, lower eyelids puffy, c/o discomfort at site of injection.  Taken to ER for evaluation.  Given Benadryl, Prednisone at ER.  Prescriptions given to mother for Zyrtec, oral Prednisolone.
Patient receive flu shot and now has pain at point of injection with slight bruising - no shoulder pain.
Chills; Flulike symptoms; Tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2022 at 14:00 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 69 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU VACCINE VII, on 13Oct2022 as dose number unknown, single. Vaccination history included: Covid-19 vaccine, for covid-19 immunisation. The following information was reported: CHILLS (non-serious) with onset 14Oct2022 at 14:30, outcome "unknown"; INFLUENZA LIKE ILLNESS (non-serious) with onset 14Oct2022 at 14:30, outcome "unknown", described as "Flulike symptoms"; FATIGUE (non-serious) with onset 14Oct2022 at 14:30, outcome "unknown", described as "Tired".   Additional information: Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other medications within two weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient called in regards to a Fluzone quad flu vaccine she received on 10/8. Following the injection, she experienced itching, redness and swelling around the injection site as well as down the rest of her arm. She took some ibuprofen which releived it but the symptoms have returned today. Advised the patient to try an antihistamine, advise their doctor, and go to the ER if she experiences any throat tightness or difficulty breathing.
pain at the site of injection; This spontaneous case was reported by a nurse and describes the occurrence of INJECTION SITE PAIN (pain at the site of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (pain at the site of injection). At the time of the report, INJECTION SITE PAIN (pain at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Fever 103.4F Rectally, Irritability, Tiredness, Diarrhea
I had rash on both arms and later spread to both of my legs; Sore Arm; This is a spontaneous report from a contactable consumer (reported for himself). A 72-year-old male patient received first dose of BNT162B2 (BNT162B2, Solution for injection, Lot number: EW0172), via an unspecified route of administration on 29Apr2021 as dose 1, single (at the age of 72-year-old) for COVID-19 immunization. Medical history included hypertension from an unknown date and unknown if ongoing, prostate cancer from an unknown date and unknown if ongoing (patient took medication for prostate). Concomitant medications included lisinopril and amlodipine, both taken for hypertension, start and stop date were not reported; dutasteride and tamsulosin, both taken for an unspecified indication, start and stop date were not reported. On 30Apr2021 (also reported as Friday about mid-morning), the patient started getting sore arm and that lasted for a day but that was not for patient was calling. On 01May2021 (also reported as Yesterday morning), the patient looked at his arms and had a rash on both arms and later in the afternoon, it spread to both of his legs, unusual side effects. Treatment was not received for events. No la tests since January. Patient called because people gave him the vaccine said him that if he had any unusual side effects, he had to let them know because may be he can't take the second shot. So he needed to get the answer to that that question should he keep his appointment to the 20May or not keep it. Seriousness for events was not specified. Outcome of the events was not recovered.   No follow-up attempts are needed. No further information is expected.
Flu like symptoms; Explosive diarrhea; she didn't feel good; inflammation; Left shoulder pain; Right shoulder, elbow, arm pain/worsened; Right shoulder, elbow, arm pain/worsened; Right shoulder, elbow, arm pain/worsened; right arm can be numb; weak.; This is a spontaneous report from a contactable consumer or other non hcp.  A 56-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection), dose 2 intramuscular on 05Apr2021 16:30 (Batch/Lot Number: EP7534) as dose 2, single for covid-19 immunisation. Medical history included ongoing irritable bowel, ongoing coeliac disease, ongoing hypertension, von Willebrand's disease, asthma. The patient's concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID.It was reported that, The patient experienced left shoulder pain on Apr2021 with outcome of recovering , right shoulder, elbow, arm pain/worsened on Apr2021 with outcome of not recovered , right shoulder, elbow, arm pain/worsened on Apr2021 with outcome of not recovered , right shoulder, elbow, arm pain/worsened on Apr2021 with outcome of not recovered , right arm can be numb on Apr2021 with outcome of not recovered , weak on Apr2021 with outcome of not recovered , flu like symptoms on an unspecified date with outcome of recovered , explosive diarrhoea on Apr2021 with outcome of recovering , she didn't feel good on Apr2021 with outcome of recovering , inflammation on Apr2021 with outcome of unknown.  Therapeutic measures were taken as a result of left shoulder pain (arthralgia), right shoulder, elbow, arm pain/worsened (arthralgia), right shoulder, elbow, arm pain/worsened (pain in extremity), right shoulder, elbow, arm pain/worsened (condition aggravated) , explosive diarrhea (diarrhoea).  Follow-Up (06Sep2021): Follow-up attempts are completed. No further information is expected.
one died after the vaccine; This is a spontaneous report from a Pfizer-sponsored program. This contactable consumer reported that a female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter reported 3 females died post vaccination with the Pfizer-BioNTech COVID-19 vaccine. She explained one died after the vaccine on an unspecified date. She explained she had no additional details on the adverse event. The patient died on an unspecified date. It was not reported if an autopsy was performed.   Information on the lot/batch number has been requested.; Reported Cause(s) of Death: one died after the vaccine
This spontaneous report was received from a Medical Assistant referring to a 12 year old patient of unknown gender. The patient's pertinent medical history included leukaemia. The patient's concurrent conditions and concomitant medications were not provided. On 27-APR-2018, the patient was vaccinated with GARDASIL 9 lot # N018273, expiration date on 17-JUN-2019, for prophylaxis (strength and dose were not reported). The Medical Assistant reported it was uncertain if GARDASIL 9 was administered either by subcutaneous or intramuscular route. No side effect were reported.
Left thigh swollen, painful; 2" redness at injection site and warmth to site.
Felt a minor headache, and tiredness directly afterwards. At 7:30 pm 12 hrs later I went through 3 hrs. of violently shaking along with feeling very chilly. Woke up with every muscle aching and a pounding headache, after 3-4 hrs. I started to feel better. The 3 hrs. of violently shaking is what I'm reporting.